Residential Property
Hong Kong's apartment market on a buying spree
Buyers spent a record $47.5b in the first quarter.
Government reveals tightened stamp duty has been effective
Buyers have been stopped from evading tax by purchasing multiple new homes.
Hong Kong to tighten property stamp duties
This is to prevent buyers from evading tax.
Property sales up 35.4% to 7,605 in March
The total sale and purchase agreements were worth $61.6 billion.
Developers to speed up launch of flats to keep up with rising demand
Up to 7,900 units are due to go on the market.
Hong Kong warns against home loan risks as prices soar
A new round of cooling measures loom ahead.
Homeowner scheme to be launched for first-time buyers
It can possibly adopt a public-private partnership model.
Approved mortgage loans dropped 2.4% to $27.6b
Whilst the number of applications slipped 0.1%.
Hong Kong government asserts property cooling measures were effective
Only 1% of purchased properties were by nong-Hong Kong residents.
Hong Kong's home prices to keep surging for the next few years
Bloomberg shows three charts to prove this point.
Kerry Properties' profit up 5% to $3.7b
Its asset value also edged up by 2%.
Why homebuyers must be extra prudent in assessing their ability to repay mortgage loans
Interest rate hikes could continue until 2019.
Realtors selling overseas properties probed by Hong Kong regulator
Individuals who lost money on at least 15 uncompleted UK developments have complained.
Homebuyers snub two recently launched projects in Hong Kong
Their increased prices found few takers.
Minimum requirements could curb Hong Kong's shrinking flat sizes
In recent years, developers have built smaller flats to meet demand.
New flats lure buyers in Hong Kong
New World Development will put on sale 99 flats.
Read Here
Advertise
Sign Up
Commentary
Hong Kong hospitality: Momentum and the new lifestyle era
Understanding Hong Kong’s new land premium policy
Hong Kong: At the forefront of digitalisation and evolving international disputes
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings